Skip to content

Comparison of block effects between heavy and plain ropivacaine in patients undergoing breast surgery under segmental thoracic spinal block

Comparison of block characteristics and outcomes of hyperbaric versus isobaric ropivacaine in patients undergoing modified radical mastectomy under segmental thoracic spinal anaesthesia: An exploratory double blind randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048040
Enrollment
60
Registered
2022-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C508- Malignant neoplasm of overlappingsites of breast

Interventions

Intervention1: Segmental thoracic spinal anaesthesia: Segmental thoracic spinal anaesthesia at T5-T6 level in patients undergoing modified radical mastcectomy of duration less than 3 hours. Control In

Sponsors

Department of Anaesthesiology, AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Female patients with breast cancer undergoing unilateral modified radical mastectomy with axillary clearance with duration less than 3 hours. 2) Age >20 years 3) ASA grading, I-III 4) BMI- 20-30 kg/m2

Exclusion criteria

Exclusion criteria: 1) Refusing to participate in study. 2) Any contraindications to sub-arachnoid block. 3) Significant cardiovascular/renal/hepatic disease. 4) Hypersensitivity to any of the study drug 5) Breast reconstructive surgery with muscle flap

Design outcomes

Primary

MeasureTime frame
Time (onset) to achieve sensory loss at T2 level in both the groupsTimepoint: 5,10,15 minutes of spinal anaesthesia

Secondary

MeasureTime frame
Intra-operative outcome- Monitoring of Hemodynamics changesTimepoint: From 0 to every 5 minutes till the end of surgery;Post-operative outcome - Post-operative pain score according to NRS scaleTimepoint: At 0/2/6/12/18/24 hours

Countries

India

Contacts

Public ContactDr Praveen Talawar

All India Institute of Medical Sciences Rishikesh

praveenrt64@gmail.com9654162941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026